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Abstract: This investigation examined the impact of Montmorency tart cherry concentrate 
(MC) on physiological indices of oxidative stress, inflammation and muscle damage across 
3 days simulated road cycle racing. Trained cyclists (n = 16) were divided into equal groups 
and consumed 30 mL of MC or placebo (PLA), twice per day for seven consecutive days.  
A simulated, high-intensity, stochastic road cycling trial, lasting 109 min, was completed on 
days 5, 6 and 7. Oxidative stress and inflammation were measured from blood samples 
collected at baseline and immediately pre- and post-trial on days 5, 6 and 7. Analyses for 
lipid hydroperoxides (LOOH), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), 
interleukin-8 (IL-8), interleukin-1-beta (IL-1-β), high-sensitivity C-reactive protein (hsCRP) 
and creatine kinase (CK) were conducted. LOOH (p < 0.01), IL-6 (p < 0.05) and hsCRP  
(p < 0.05) responses to trials were lower in the MC group versus PLA. No group or 
interaction effects were found for the other markers. The attenuated oxidative and 
inflammatory responses suggest MC may be efficacious in combating post-exercise 
oxidative and inflammatory cascades that can contribute to cellular disruption. Additionally, 
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we demonstrate direct application for MC in repeated days cycling and conceivably other 
sporting scenario’s where back-to-back performances are required. 
Keywords: recovery; strenuous exercise; muscle damage; prunus cerasus 
 
1. Introduction 
Antioxidant supplementation has received growing attention for its role in aiding recovery from 
strenuous exercise [1–3] due to its ability to reduce cell damaging oxidative stress [4–8] and 
inflammation [9–11]. Specifically, the efficacy of antioxidant supplements such as ascorbic acid 
(vitamin C) [12–14], α-tocopherol (vitamin E) [15,16] and a range of functional foods with high 
antioxidant concentrations such as blueberries [17], beetroot [18,19] and cherries [10,20,21], have 
been investigated with regards to accelerating recovery or enhancing physical performance. 
It has been suggested that foods with a high concentration of the flavanoids, anthocyanins, may be 
beneficial in recovery from exercise, which is proposed to increase the capacity for the inhibition of 
inflammatory cyclooxygenase (COX-1 and COX-2) enzymes and oxidative stress [6,22]. 
Anthocyanins are glycosides of their aglycon, cyanidin, and have been shown (in vitro) to be superior 
to α-tocopherol and the commercially available antioxidants butylated hydroxyanisole (BHA) and 
butylated hydroxytoluene (BHT) in the attenuation of lipid peroxidation [6]. Additionally, 
anthocyanins from Montmorency cherries have demonstrated similar anti-inflammatory properties to 
non-steroidal anti-inflammatory drugs (NSAID’s), such as ibuprofen and naproxen [22] and were 
superior to blueberries, cranberries and bilberries. Furthermore, a cell culture study in rat hepatocytes 
demonstrated anthocyanins inhibited reactive oxygen species (hydrogen peroxide) whilst up-regulating 
the expression of endogenous antioxidants glutathione reductase, glutathione peroxidase and glutathione 
S-transferase [23]. 
Montmorency cherries are a good candidate for recovery following intense exercise in humans 
because of their high concentrations of anthocyanins [5]. The first study to demonstrate accelerated 
exercise recovery used 9 days of Montmorency cherry supplementation (4 days pre-, on the day and 4 days 
post-exercise) [20]. In the 96 h following an eccentric-induced muscle damage protocol, 
supplementation with Montmorency cherries showed significant attenuation in the decline of isometric 
strength when compared with a placebo (4% vs. 22%). This was supported more recently by research 
demonstrating that 10 days of Montmorency cherry supplementation (7 days pre-, on the day and 2 days 
post-exercise) resulted in a more rapid recovery of isokinetic knee extensor force than an isoenergetic 
placebo following an eccentric-induced muscle damage protocol [21]. Despite these findings neither 
study was able to demonstrate changes in oxidative stress or inflammation, although a trend towards 
attenuated oxidative stress (protein carbonyls) was reported in the latter study with Montmorency 
cherries condition [21]. In addition to the aforementioned studies, attenuation of both oxidative stress 
and inflammatory responses to exercise with Montmorency cherries supplementation (8 days; 5 days 
pre-, on the day of and 2 days post-exercise) have been demonstrated following marathon running [10]. In 
the 48 h following marathon running, participants supplemented with Montmorency cherries showed 
significantly lower oxidative stress (thiobarbituric acid reactive substances [TBARS]) than the placebo 
Nutrients 2014, 6 831 
 
counterparts and in addition, the inflammatory response (interleukin-6 [IL-6] and high-sensitivity 
C-reactive protein [hsCRP]) were significantly lower in the Montmorency cherries versus placebo 
group. The discrepancies in findings with regards to biomarkers of oxidative stress and inflammation 
between Howatson et al., (2010) [10] and Bowtell et al., (2011) [21] may be explained by the mode of 
exercise used in the studies. Whilst Bowtell et al., (2011) [21] used a protocol to induce stress via  
a mechanically challenging exercise (eccentric muscle actions), the marathon running used by 
Howatson et al., [10] induced stress via both mechanical and metabolic pathways. Exercise that 
involves maximal muscular contractions such as those performed in Bowtell et al., (2011) [21] derives 
energy primarily from anaerobic pathways (ATP-PC system and anaerobic glycolysis) [24] and 
generally induces a high degree of mechanical stress on the muscle; whereas endurance exercise 
requires more prolonged energy turnover from aerobic sources (aerobic glycolysis and beta oxidation). 
Differences in energy pathway required impacts upon the magnitude and type of stress caused by the 
exercise with maximal muscular contractions causing greater mechanical damage (particularly when 
eccentric in nature) [25,26]. Running a marathon provides high mechanical stress through eccentric 
muscle actions and a high metabolic cost due to the requirements of sustained higher energy 
expenditure associated with this activity. This finding suggests that the positive effects of 
Montmorency cherries on recovery may be well suited to exercise with a high metabolic component. 
To date, no study has investigated the effects of Montmorency cherry supplementation on recovery 
from exercise that induces stress almost exclusively through metabolic pathways. Cycle ergometry 
provides an exercise model with little or no eccentric component. Additionally, repeated days 
strenuous cycling (akin to road cycling stage races) provides a suitable exercise paradigm for 
investigating repeated days performance in a metabolically challenging exercise, that has the scope to 
cause temporary perturbations inflammation and oxidative stress. Based on the evidence from previous 
literature, it was hypothesised that Montmorency cherry supplementation would attenuate the oxidative 
and inflammatory responses to the metabolic stress imposed via cycling across 3 days. As a result, the 
aim of the study was to investigate the impact of Montmorency cherries on metabolically exercise-induced 
oxidative stress and inflammation across 3 days of simulated cycle road racing. 
2. Experimental Section 
2.1. Participants 
Sixteen well-trained, male cyclists (mean ± SD age, height, mass, VO2peak was 30 ± 8 years;  
181.1 ± 6.7 cm, 76.5 ± 9.2 kg, 61.6 ± 10.4 mL·kg−1·min−1, respectively) were recruited to take part in 
the study following completion of a medical health-screening questionnaire. Volunteers were excluded 
from the study if they met any of the following exclusion criteria; current smoking habit, food allergy 
(discussed with research team), current use of any food supplements, history of gastrointestinal, renal 
or cardiovascular disease. Institutional ethical clearance was granted by the Northumbria University, 
Faculty of Health and Life Sciences Research Ethics Committee prior to any testing and written 
informed consent was collected from all participants following both verbal and written briefings on the 
requirements of the study. 
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2.2. Study Design 
All elements of the study were conducted in laboratories accredited by the British Association of 
Sport and Exercise Sciences (BASES). The study utilised a double-blind, independent groups design 
and required participants to complete a trial period of 8 days, including 4 visits to the laboratory 
(Figure 1). Visit 1 consisted of a preliminary aerobic profiling (VO2peak, Wmax) and familiarisation 
session, following which, the 16 participants were randomly, but equally divided into two groups 
(Montmorency cherry concentrate [MC] or Placebo [PLA]), that were counterbalanced by VO2peak 
(63.1 vs. 60.2 mL·kg·min−1). Visits 2–4 were conducted on consecutive days following a 4-day 
supplement loading phase and required participants to complete the exercise protocol described.  
Each visit started at 7:45 am following a 10 h overnight fast. Blood samples for analysis of systemic 
markers of oxidative stress, inflammation and muscle damage were collected at baseline  
(prior to 4-day loading phase), pre-trial 1, post-trial 1, pre-trial 2, post-trial 2, pre-trial 3 and post-trial 3. 
Figure 1. Schematic of testing protocol. Trials took place on consecutive days at 8:00 am 
following an overnight fast. 
 
2.3. Supplementation and Dietary Control 
Participants were provided with either MC or PLA supplementation after the initial visit and 
instructed to take the 30 mL of the supplement twice per day (8 am, 6 pm), for 7 consecutive days (4 days 
pre- and on each trial day [21]. All supplements were mixed with 100 mL of water prior  
to consumption. Independent analysis of MC [27] provided the following compositional data;  
Fat 0.028 mg·mL−1, Protein 31.47 mg·mL−1, Carbohydrate 669.4 mg·mL−1, Cholesterol < 0.01 mg·mL−1,  
Sodium 0.691 mg·mL−1, Calcium 0.137 mg·mL−1 and Iron 0.026 mg·mL−1. Additionally, according to 
the manufacturers guidelines (Cherry Active, Hanworth, UK), a 30 mL dose of MC is equivalent to 
approximately 90 whole Montmorency tart cherries and has been previously reported to contain 9.117 mg·mL−1 
of anthocyanins [5,21,28]. The PLA supplement consisted of a commercially available, less than 5% 
fruit, cordial (Protein 20 mg·mL−1, Carbohydrate 260 mg·mL−1, Sodium 10 mg·mL−1, Fat–Trace, 
Fibre–Trace and Anthocyanins–Trace for colour), mixed with water and maltodextrin  
(MyProtein Ltd., Northwich, UK) until matched for carbohydrate content of the MC. An independent 
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member of the department prepared and provided all supplements in opaque bottles to participants in 
order to maintain the double blind design. 
Throughout the course of the trial period, participants were required to adhere to a low-polyphenolic 
diet requiring the avoidance of fruits, vegetables, tea, coffee, alcohol, chocolate, cereals, wholemeal 
bread and grains. Verbal and written explanations of foods to avoid and detailed examples of suitable 
foods and diets were provided. In order to assess for dietary compliance, participants completed food 
diaries for the duration of the study [28]. 
2.4. Exercise Protocol 
Participants completed a simulated cycling road race at 8 am on visits 2–4. The cycling task was 
performed using a magnetically braked cycle ergometer (Velotron RacerMate, Seattle, WA, USA) and 
was a prolonged, high-intensity, stochastic performance previously used to simulate cycling road race 
demands [29]. Briefly, following a 10 min self-selected warm-up including 3 × 3 s sprints at 7, 8 and  
9 min, participants completed 66 sprints lasting 5, 10 or 15 s, with a work (W) to rest ratio of 1:6, 1:3 
or 1:1. Sprints were divided into 9 sets, with an active recovery period taking place between sets 1–2, 
2–3, 4–5, 5–6, 7–8 and 8–9. All active recovery and rest periods were maintained at an intensity equal 
to 40%–50% Wmax. A further 9 min of sustained effort was incorporated into the task through the 
performance of 2 × 2 min and 1 × 5 min time-trials following the active recovery periods after sets 3, 6 
and 9. During all time-trials, participants were encouraged to complete as much work as possible and 
the total duration of the trial was 109 min. Heart rate was continually recorded throughout each trial, 
using wireless heart rate telemetry (Polar Electro Ltd., Kempele, Finland). Additionally, power output 
(Velotron RacerMate, Seattle, WA, USA) data was collected at a frequency of 3 Hz and subsequently 
transformed into work performed (kJ). Throughout all trials, water was made available to participants 
ad libitum and strong verbal encouragement was provided. The exercise protocol is presented in Table 1. 
2.5. Blood Sampling 
Venous blood samples were collected from a branch of the basilic vein in the anti-cubital fossa 
region using the venepuncture method. A total ~21 mL of blood was collected into di-potassium 
ethylene diamine tetra-acetic acid (EDTA 10 mL), sodium heparin (6 mL) and serum separator (5 mL) 
tubes, respectively. Tubes were immediately centrifuged at 2400× g, 4 °C for 15 min, prior to the 
supernatant being removed and stored in aliquots at −80 °C. 
Table 1. Simulated road cycling race protocol (Vaile et al., 2008) [29]. Work—Maximal 
effort sprint. Rest—Power at 40%–50% Wmax. ACT (Active recovery)-Power at 40%–50% 
Wmax. TT (Time Trial)—Sustained maximal effort. 
10 minute warm up (Self-selected pace) 
Set Number  Sprint Frequency/Duration  Work to Rest Ratio  
Set 1  12 × 5 s  1:6 (Work:Rest)  
Set 2  12 × 5 s  1:3 (Work:Rest)  
Set 3  12 × 5 s  1:1 (Work:Rest)  
4 min ACT-2 min TT-4 min ACT  
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Table 1. Cont. 
Set 4  6 × 10 s  1:6 (Work:Rest)  
Set 5  6 × 10 s  1:3 (Work:Rest)  
Set 6  6 × 10 s  1:1 (Work:Rest)  
4 min ACT-2 min TT-4 min ACT  
Set 7  4 × 15 s  1:6 (Work:Rest)  
Set 8  4 × 15 s  1:3 (Work:Rest)  
Set 9  4 × 15 s  1:1 (Work:Rest)  
5 min ACT-5 min TT-5 min ACT  
2.6. Oxidative Stress 
To assess oxidative stress, samples were analysed for aqueous phase lipid hydroperoxides (LOOH) 
via the ferrous oxidation of xylenol orange method (FOX 1), using a modification of the methods by 
Wolff (1994) [30] and Nourooz-Zadeh et al., (1994) [31]. Absorbance was read spectrophotometrically 
(U-2001, Hitachi, England) at 560 nm against a linear standard curve (range 0–5 µmol·L−1).  
The inter-assay and intra-assay coefficients of variation were <4% and <2%, respectively. 
2.7. Inflammatory Indices 
Plasma tumour necrosis factor-alpha (TNF-α), interleukin-1-beta (IL-1-β), interleukin-6 (IL-6) and 
interleukin-8 (IL-8) were analysed using a multiplex electrochemiluminescence assay and plate reader 
(Sector Imager 2400, Meso Scale Discovery, Rockville, MD, USA). The intra- and inter-plate 
coefficients of variation were; 6.8% and 9.5% (IL-1-β), 4.9% and 8.8% (IL-6), 3.41% and 8.5% (IL-8), 
4.64 and 11.5% (TNFα) respectively. Serum high sensitivity C-reactive protein (hsCRP) was analysed 
using an immunoturbidimetric assay (Roche Modular P, Roche Diagnostics Ltd., Burgess Hill, UK). 
Inter- and intra-assay coefficients of variation were 4.7% and 0.7%,respectively. 
2.8. Muscle Damage 
Serum creatine kinase (CK) was analysed using a kinetic UV test (Olympus Analyser, Olympus 
Diagnostica GmbH, Hamburg) in line with the recommendations of the International Federation of 
Clinical Chemistry (IFCC). Inter- and intra-assay coefficients of variation were both 1.5%. 
2.9. Statistical Analysis 
All data was analysed using statistical software (IBM SPSS 20 for Windows, New York, NY, USA) 
and are reported as mean ± standard deviation. Blood indices were anlaysed using a group (MC v PLA) by 
time-point (baseline, pre-trial 1, post-trial 1, pre-trial 2, post-trial 2, pre-trial 3, post-trial 3) repeated 
measures analysis of variance (ANOVA). The ANOVA analyses for heart rate and work done during 
the time-trial phases included four fewer time-point levels (Trial 1, Trial 2, Trial 3). Mauchley’s Test 
of Sphericity was conducted to test for homogeneity of data and where violations were present; 
Greenhouse-Geiser adjustments were made. LSD post-hoc analysis was used, where necessary, to 
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identify significant interaction effects. A significance level of p < 0.05 was set prior to all analyses. 
Where appropriate, data were normalised using percentage to account for differences in baseline measures. 
3. Results 
Serum LOOH (Figure 2) showed significant time (F (1,7) = 2.631, p =  0.022), group (F(1,2) = 15.919, 
p < 0.001) and interaction effects (F (1,7) = 3.956, p < 0.002). LOOH were elevated above baseline in 
the PLA group across the trial period, whilst the MC supplemented group demonstrated attenuated 
LOOH responses in the same period. The greatest difference between MC and PLA occurred 
following trial 3 where LOOH was 29.8% lower in the MC supplemented group. 
Figure 2. Serum lipid hydroperoxide responses (% Change from baseline) to Montmorency 
cherry concentrate (MC) and isoenergetic placebo (PLA). Absolute baseline values  
were 1.269 ± 0.085 and 1.189 ± 0.153 mmol mL−1 for MC and PLA respectively.  
* Significant group effect (p < 0.05), $ Significant interaction effect (p < 0.05); values are 
mean ± SD. 
 
The pro-inflammatory marker, IL-6 (Figure 3), demonstrated time (F (1,7) = 21.412, p < 0.001), 
group (F (1,2) = 4.722, p =  0.047), and interaction effects (F (1,7) = 2.803, p < 0.016) with lower values 
present in the MC vs. PLA group immediately following trial 2 (2.03 pg·mL−1) and trial 3 (1.63 pg·mL−1) 
(F (1,7) = 2.803, p < 0.05). Significant time (F (1,7) = 7.467, p < 0.001), group (F (1,2) = 4.726, p =  0.047) 
and interaction (F (1,7) = 2.534, p = 0.026) effects were also found for hsCRP, which was lower in the 
MC group across all time-points after baseline (Figure 4). A main effect of time was found for IL-8 
(F (1,7) = 15.411, p < 0.001), however there were no group or interaction differences present. No 
differences were found between IL-1-β or TNF-α (Table 2). 
Muscle damage (CK) was not different between groups. However, CK did demonstrate a significant 
main effect for time (F (1,7) = 3.213, p = 0.007), with a small mean increase of 77 U/I across the trial 
period (Table 2). Total work performed (kJ) during the time-trial phases decreased across each trial 
with a main effect for time (F (1,3) = 7.667, p < 0.05) apparent. However, no differences between groups 
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or interaction effects were found. Heart rate analysis during time-trial phases revealed no differences 
between groups or across the three trials (Table 3). 
Figure 3. Plasma interleukin-6 responses (pg·mL−1) to Montmorency cherry concentrate 
(MC) and isoenergetic placebo (PLA). * Significant group effect (p < 0.05), $ Significant 
interaction effects (p < 0.05); values are mean ± SD. 
 
Figure 4. High-sensitivity CRP responses (% Change from baseline) to Montmorency 
cherry concentrate (MC) and isoenergetic placebo (PLA). Absolute baseline values were  
0.889 ± 0.592 and 0.475 ± 0.191 pg·mL−1 for MC and PLA respectively. * Significant group 
effect (p < 0.05), $ Significant interaction effects (p < 0.05); values are mean ± SD. 
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Table 2. Markers of inflammation and muscle damage not different between groups. 
 Baseline Pre-trial 1 Post-trial 1 Pre-trial 2 Post-trial 2 Pre-trial 3 Post-trial 3 
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
IL-1-β (pg mL−1) 
MC 0.09 0.15 0.10 0.17 0.06 0.08 0.05 0.09 0.14 0.20 0.10 0.15 0.08 0.12 
PLA 0.27 0.47 0.11 0.14 0.20 0.22 0.20 0.29 0.19 0.29 0.16 0.20 0.13 0.18 
IL-8 (pg mL−1) * 
MC 2.34 0.96 2.67 0.95 4.75 0.63 2.68 0.95 3.68 1.35 2.39 1.07 3.76 1.42 
PLA 3.21 1.30 3.20 1.22 5.30 2.14 2.94 0.92 4.07 1.12 2.76 1.04 3.86 1.11 
TNF-α (pg mL−1) 
MC 1.66 0.52 1.50 0.49 1.91 0.58 1.66 0.58 1.51 0.56 1.50 0.58 1.70 0.40 
PLA 1.87 0.85 1.64 0.71 1.94 0.72 1.65 0.86 1.62 0.85 1.64 0.79 1.76 0.81 
CK (IU/L) * 
MC 146.0 57.2 146.0 57.2 245.8 96.3 206.0 120.7 188.0 83.1 224.3 100.4 169.0 65.1 
PLA 128.7 74.0 128.7 74.0 180.4 77.0 279.3 310.8 222.7 91.6 287.0 153.6 292.7 231.3 
*: Significant main effect for time (p < 0.05); IL-1-β: Interleukin-1-beta; IL-8: Interleukin-8; TNF-α: Tumour Necrosis Factor-Alpha; CK: Creatine Kinase. 
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Table 3. Time trial data. 
Trial 1 Trial 2 Trial 3 
Mean SD Mean SD Mean SD 
Heart Rate (b·min−1) 
MC 160.89 21.32 162.01 24.90 159.09 22.29 
PLA 158.45 18.63 160.84 21.11 159.70 20.12 
Work Performed (kJ) * 
MC 151.90 29.49 148.40 30.03 139.19 29.64 
PLA 145.35 39.05 141.71 39.84 139.79 38.47 
*: Significant main effect for time (p < 0.05). 
Although food consumption during the trial phases was not subject to detailed dietary scrutiny, all 
food diaries were reviewed for compliance with dietary restrictions. Analysis of diaries demonstrated 
100% adherence to dietary restrictions. 
4. Discussion 
This is the first study to investigate the impact of Montmorency cherries on systemic inflammatory 
and oxidative stress induced by a series of metabolically challenging cycling bouts. Despite both 
groups demonstrating a similar drop off in performance and no differences in time trial performance, 
the results show that both oxidative stress and inflammatory responses were attenuated with MC 
supplementation versus PLA. 
Oxidative stress, as measured by LOOH, was lower in the MC and PLA groups across all time 
points following baseline measures. Interestingly, in the MC group, LOOH did not rise above baseline 
at any time point, although concentration did rise towards baseline following each bout. In contrast, 
LOOH in the PLA group remained above baseline values throughout the duration of the study.  
These findings concur with previous work; following marathon running [10], participants supplemented 
with MC showed no increases in TBARS (lipid peroxidation), whereas a PLA group demonstrated 
increased TBARS at 48 h post-exercise. The use of TBARS as a measure of lipid peroxidation has 
been criticised due to a lack of specificity in human models because the assay also reacts with 
prostaglandins, carbohydrates and both saturated and unsaturated non-functional aldehydes at 532 nm [32]. 
Conversely, LOOH have been shown to be a valid measure of post-exercise induced lipid peroxidation, 
and they are a reliable measure of cell membrane phospholipid damage [33]; consequently the data from 
the current study using LOOH suggest that lipid peroxidation is reduced with MC supplementation. 
An interesting finding of note was the opposing changes in LOOH from baseline to pre-trial 1 
between groups, whereby LOOH was reduced in the MC group by ~11% and raised in the PLA group 
by ~5%. This suggests that the antioxidant capacity of MC may have influenced redox balance and 
antioxidative capacity prior to exercise as other potential sources of dietary antioxidants were excluded 
from the diet. Although this is somewhat speculative, the removal of potential sources of antioxidants 
in the PLA group diet may have reduced antioxidant status and resulted in conditions suitable for 
increased lipid peroxidation. Antioxidant status was not measured in the current study, however, 
previous work using Montmorency cherries has demonstrated that an increase in oxidative stress can 
become apparent at the same time point that total antioxidant status falls below baseline levels [10], 
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hence providing supporting for our supposition. The decreased LOOH in MC and increased LOOH in 
PLA across the duration of the study provide support that antioxidant capacity between groups was 
probably different. 
Average increases of LOOH from pre-to-post trial in the MC group were lower than those in the 
PLA group (5% vs. 11%). The potential mechanisms for these observations are currently unknown, 
however the supplementation of MC make it possible that a number of events may have contributed to 
the findings; direct scavenging of free radical species responsible for damaging cells [34], formation of 
complexes resistant to free radical attack [35], up-regulation of endogenous enzymatic antioxidant 
defence systems [23] or lastly a synergistic combination of these [5,23,36]. 
Direct free radical scavenging alone would unlikely be responsible for the lowered LOOH found, as 
anthocyanins, the prominent antioxidant group within MC, are poorly absorbed [37,38] and are quickly 
excreted from the system [39,40] in humans. Additionally although an in vitro study has demonstrated 
the formation of complexes resistant to oxidative damage with anthocyanins mixing, this was only 
shown with DNA and not lipid structures, and is therefore not likely to have impacted on the LOOH 
levels in the current study [35]. The up-regulation of endogenous antioxidant enzyme defences seems 
to provide the most likely candidate mechanism of protection against lipid peroxidation. Anthocyanins 
have been shown to increase the expression of glutathione related antioxidant enzymes (glutathione 
peroxidase, glutathione reductase and glutathione-S-transferase) in rat hepatocytes [23]. It is possible 
that the consumption of MC triggered such a response and resulted in a greater capacity for the 
removal of free radical species responsible for the lipid peroxidation. Indeed, such enzymes have been 
implicated in both the prevention of lipid peroxidation (via reduction of hydrogen peroxide [H2O2]) 
and the removal of LOOH (via 2 electron reduction to inert alcohols and water) [33]. Although other 
mechanisms cannot be ruled out, this provides the most tenable explanation for the findings of reduced 
LOOH with MC consumption in the present study. In order to investigate this supposition, future 
research should look to address changes in both endogenous and exogenous antioxidant responses 
following MC supplementation. 
The attenuation of post-exercise inflammation provides further support for the use of MC in the 
acceleration of recovery. In agreement with previous research, IL-6 and hsCRP [10] were both 
attenuated in the MC group. Interestingly, IL-6 increased following trial 2 and 3, which was greater in 
the PLA versus the MC group. Furthermore, there was little difference following trial 1, suggesting 
that MC has an inflammatory blunting response with cumulative bouts of metabolically strenuous 
exercise. Additionally, the attenuation of the rise in hsCRP, demonstrated a decreased secondary 
inflammatory response in the MC group. The reduction in both primary and secondary inflammatory 
responses to each trial in the MC group may be a downstream effect of reduced cell damage through 
oxidative stress during exercise. Conversely, the PLA group demonstrated a sharp increase in hsCRP 
following trial 1, which was maintained at an elevated level in accordance with increased LOOH 
across the remainder of the trial, a further indication that LOOH may have influenced the 
inflammatory state. It must also be noted however, that an increase in inflammation can contribute to a 
rise in oxidative stress [8], and as a result, it is conceivable that a reduction in inflammatory response 
was responsible for the observed attenuation in lipid peroxidation. 
Both IL-6 and hsCRP values were considerably lower than those obtained following marathon 
running [10,41] and eccentric knee extensions [21], suggesting that the magnitude of the inflammatory 
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response is significantly modulated by mechanically damaging components of exercise as opposed to 
the exclusively metabolic stress imposed in the current study. Nonetheless, the lower hsCRP response 
across the duration of the trial suggests that MC attenuates inflammation, which may have implications 
for clinical populations, particularly those who demonstrate low-grade chronic inflammation. 
Results demonstrated drops in time-trial performances that were not different between groups 
across the three trials, providing evidence that the same degree of exercise stress was placed upon each 
group. Additionally, no differences in CK between groups were apparent, although a very small 
increase in CK was noted; suggesting a minimal amount of muscle damage was caused. As a result, 
greater confidence can be placed upon the proposed effects of MC on the oxidative stress and 
inflammatory responses discussed. 
Oxidative stress and inflammation are linked with damage to the cell’s structure and function and 
the blunting of such responses following MC supplementation in the current study may be expected to 
influence functional performance. Although not a specific aim of this investigation, an acknowledged 
limitation is that no measure of functional performance, such as muscular strength or power, was 
included either prior to or following trials. In order to investigate this, future work should look to use a 
similar model of high-intensity cycling to identify the effect of metabolic stress on exercise-induced 
oxidative stress and inflammation, and the influence of these on specific measures of muscle function 
and performance. 
5. Conclusions 
This study is the first to demonstrate attenuated oxidative stress and inflammation responses 
following supplementation with MC in an exercise task that induced stress almost exclusively from 
metabolic pathways. We postulate that the observed reductions in oxidative stress and inflammation 
are associated with a greater ability to combat inflammation and the subsequent cascade of oxidative 
stress. Additionally, we demonstrate a direct application for MC during repeated days, high intensity 
cycling and conceivably other sporting scenarios where back-to-back performances cause appreciable 
levels of inflammation and oxidative stress. Further research should focus on a range of performance 
measures in order to identify the consequences of the exercise stimulus and the interaction of MC, 
oxidative stress, inflammation and human performance. Such research would provide application to 
other sporting scenario’s where there is a high metabolic stress component, such as team invasion sports. 
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